HB813: Maryland Insurance Administration and Maryland Department of Health - Workgroup to Study Pharmacy Benefits Managers
Legislative Summary
Requiring the Maryland Insurance Administration and the Maryland Department of Health, in consultation with the Prescription Drug Affordability Board, to convene a workgroup to study and review reimbursement for pharmacists; and requiring the workgroup to submit an interim report by December 31, 2025, and a final report on their findings and recommendations to certain committees of the General Assembly by December 31, 2026.
Demographic Impact
Overall analysis of equity impact
Unlock Full Demographic Insights
Go beyond the overall score.
Gain a deeper understanding of this bill's potential impact across diverse communities, including detailed breakdowns by category and subgroup. Access to this granular analysis helps ensure equitable outcomes.
Enable full analysis features for your organization.
Contact Sales to Learn MoreOr email us directly at sales@legiequity.us.
Bill History
Amendments
Favorable with Amendments 683624/1 Adopted
Favorable with Amendments 683624/1 Adopted
Favorable with Amendments 873820/1 Adopted
Favorable with Amendments 873820/1 Adopted
Roll Call Votes
Status Information
Sponsors
Primary Sponsor
